Transthyretin Predicts Cardiovascular Outcome In Hemodialysis Patients With Diabetes Mellitus Type 2

• Váldodahkkit: Andrea Henze (Dahkki), Katharina Espe (Dahkki), Christoph Wanner (Dahkki), Vera Krane (Dahkki), Jens Raila (Dahkki), Berthold Hocher (Dahkki), Florian J. Schweigert (Dahkki), Christiane Drechsler (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: The Korean Society of Nephrology, 2012-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BMI and albumin are commonly accepted parameters to recognize wasting in dialysis patients and are powerful predictors of morbidity and mortality. However, both parameters reveal limitations and may not cover the entire range of patients with wasting. The visceral protein transthyretin (TTR) may be...